Federal Grant Award Summary

The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $144,372.00 to The Washington University under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 15, 2026, with completion targeted for April 30, 2031. This K02 Career Development Award supports integrated research and career development activities focused on advancing the implementation speed and scale-up of personalized tobacco use treatment approaches. The project addresses critical gaps in tobacco use treatment delivery by investigating how genetics-informed behavioral interventions and personalized guidance can be brought to market more rapidly and deployed across broader populations to improve smoking cessation outcomes.

The research leverages existing data from two active National Institutes of Health R01 trials to examine factors influencing implementation speed and scale-up of personalized tobacco use treatment innovations. The project combines precision medicine approaches—utilizing genetics and biological markers to customize patient risk assessment and treatment recommendations—with implementation science methodologies to ensure evidence-based treatments reach patients who would benefit from them. The work is conducted at The Washington University's Office of Sponsored Research Services Division in St. Louis, Missouri, and supports the recently tenured principal investigator's scientific leadership development in the substance use and implementation science fields.